ALLAN GUERRA: Open Payments
NPI 1679830798 · BRICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 24 payments from 11 companies in 2025. Trend: 2023 $65 · 2024 $460 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| Phathom Pharmaceuticals, Inc. | 4 | $61 |
| ABBVIE INC. | 3 | $52 |
| Janssen Biotech, Inc. | 3 | $50 |
| Braintree Laboratories, Inc. | 2 | $38 |
| Ardelyx, Inc. | 2 | $32 |
| Madrigal Pharmaceuticals | 2 | $30 |
| GENZYME CORPORATION | 1 | $21 |
| VIVUS LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: VOQUEZNA, TREMFYA, EOHILIA, LINZESS, GATTEX, IBSRELA, REZDIFFRA, DUPIXENT.
Industry payments across NJ — which companies pay providers there.
